NICE guidance and manufacturer recommendations emphasise gradual dose escalation, typically starting at the lowest available dose and increasing slowly over several weeks or months
Engineered to activate glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, Retatrutide has shown promising preclinical results in studies of metabolic regulation, weight management, and glycemic control
Now it is commonly used to treat hair loss as Rogaine and other brands
The prevalence of hyperkalemia was 10.5%
"With orforglipron, we're working to transform obesity care by introducing a potential once-daily oral therapy that could support early intervention and long-term disease management, while offering a convenient alternative to injectable treatments," Kenneth Custer, an executive vice president and president of Lilly Cardiometabolic Health, said in a statement